Overview
Disorder of pterin metabolism is a group of rare inherited conditions that affect the body's ability to make or recycle pterins, which are small molecules essential for producing important brain chemicals (neurotransmitters) like dopamine and serotonin. Pterins, especially a substance called tetrahydrobiopterin (BH4), also play a key role in breaking down the amino acid phenylalanine. When pterin metabolism does not work properly, harmful levels of phenylalanine can build up in the blood (similar to phenylketonuria or PKU), and the brain may not produce enough neurotransmitters needed for normal movement, mood, and thinking. Symptoms often appear in infancy or early childhood and can include developmental delay, movement problems such as stiffness or tremors, difficulty controlling body movements (dystonia), seizures, and intellectual disability. Some children may initially be identified through newborn screening for elevated phenylalanine levels, but further testing is needed to distinguish pterin disorders from classic PKU. Treatment depends on the specific type of pterin disorder and may include BH4 supplementation (sapropterin), neurotransmitter precursors such as L-dopa and 5-hydroxytryptophan, and dietary management to control phenylalanine levels. Early diagnosis and treatment are critical because prompt therapy can significantly improve neurological outcomes. Without treatment, the condition can lead to severe and progressive neurological damage. Lifelong management by a specialized metabolic team is typically required.
Key symptoms:
Developmental delayIntellectual disabilityMuscle stiffness or rigidityInvoluntary muscle contractions (dystonia)TremorsSeizuresDifficulty swallowingExcessive droolingProblems with movement and coordinationLow muscle tone in infancyIrritabilitySleep disturbancesTemperature instabilityElevated phenylalanine on newborn screeningMood and behavioral changes
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Disorder of pterin metabolism.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Disorder of pterin metabolism at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Disorder of pterin metabolism.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Disorder of pterin metabolism.
Community
No community posts yet. Be the first to share your experience with Disorder of pterin metabolism.
Start the conversation →Latest news about Disorder of pterin metabolism
No recent news articles for Disorder of pterin metabolism.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific type of pterin metabolism disorder does my child have, and which gene is affected?,What medications will be needed, and how will doses be adjusted over time?,Will my child need a special diet, and should we work with a metabolic dietitian?,How often will blood tests, urine tests, or spinal fluid tests be needed?,What developmental milestones should I watch for, and when should I be concerned?,Are there clinical trials or new treatments being studied for this condition?,What is the long-term outlook for my child with treatment?
Common questions about Disorder of pterin metabolism
What is Disorder of pterin metabolism?
Disorder of pterin metabolism is a group of rare inherited conditions that affect the body's ability to make or recycle pterins, which are small molecules essential for producing important brain chemicals (neurotransmitters) like dopamine and serotonin. Pterins, especially a substance called tetrahydrobiopterin (BH4), also play a key role in breaking down the amino acid phenylalanine. When pterin metabolism does not work properly, harmful levels of phenylalanine can build up in the blood (similar to phenylketonuria or PKU), and the brain may not produce enough neurotransmitters needed for norm
How is Disorder of pterin metabolism inherited?
Disorder of pterin metabolism follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Disorder of pterin metabolism typically begin?
Typical onset of Disorder of pterin metabolism is infantile. Age of onset can vary across affected individuals.